IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Akero Therapeutics Inc

CUSIP: 00973Y908 | 7 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile